Ventures Vii Lp Cmea is 10% at Auspex Pharmaceuticals, Inc. (ASPX). They have made 10 open-market trades across 2 companies since 2014, most recently 2015-04-08.
CIK 0001405712
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.4M since 2014, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASPX | SELL | 2015-02-09 | 2015-02-11 | $61.06 | $5.1M | N/A | N/A | N/A |
| ASPX | SELL | 2014-10-29 | 2014-10-31 | $27.15 | $516K | N/A | N/A | N/A |
| ASPX | SELL | 2014-10-27 | 2014-10-29 | $27.02 | $392K | N/A | N/A | N/A |
| ASPX | SELL | 2014-10-23 | 2014-10-27 | $26.97 | $445K | N/A | N/A | N/A |
| ASPX | SELL | 2014-10-06 | 2014-10-15 | $23.45 | $167K | N/A | N/A | N/A |
| ASPX | SELL | 2014-08-29 | 2014-09-03 | $22.59 | $197K | N/A | N/A | N/A |
| ASPX | SELL | 2014-08-27 | 2014-08-29 | $22.03 | $652K | N/A | N/A | N/A |
| ASPX | SELL | 2014-08-26 | 2014-08-28 | $21.35 | $135K | N/A | N/A | N/A |
| ASPX | SELL | 2014-08-22 | 2014-08-26 | $20.56 | $35K | N/A | N/A | N/A |
| ARDX | BUY | 2014-06-24 | 2014-06-26 | $14.00 | $4.4M | -44.0% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.